Inhibition of Factor Xa by a Peptidyl-α-ketothiazole Involves Two Steps. Evidence for a Stabilizing Conformational Change
- 8 October 1999
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 38 (44) , 14582-14591
- https://doi.org/10.1021/bi990958a
Abstract
Recently, peptidylketothiazoles have been shown to be potent inhibitors of proteases, but the details of the interaction have not yet been studied. In the work presented here, the interaction of factor Xa, a coagulation protease, with the transition state inhibitor BnSO2-d-Arg-Gly-Arg-ketothiazole (C921-78) is characterized. C921-78 is a tight and selective inhibitor of the coagulation protease factor Xa (Kd = 14 pM). The hydrolytic activity of factor Xa was inhibited by C921-78 in a time-dependent manner. The rate-limiting step of the bimolecular combination of inhibitor and enzyme was competitive with the substrate. Conversely, the inhibitor could be displaced from the active site of the enzyme after exposure of the preformed complex to an excess of substrate or to the active site inhibitor dansyl-Glu-Gly-Arg-chloromethyl ketone (DEGR-CMK) in a slow reaction. The formation of the C921-78−factor Xa complex resulted in a 60% increase in the magnitude of the fluorescence emission spectrum. Rapid mixing of the enzyme and inhibitor produces a monophasic fluorescence increase, compatible with spectral transition in a single step. The rate constant for this reaction increased hyperbolically with the concentration of C921-78, but the amplitude remained constant. These results are consistent with the initial formation of an enzyme−inhibitor complex (EI), followed by a unimolecular conversion of EI to EI* linked to a spectral transition. The rate constants of the isomerization provide an estimate of 300000-fold stabilization. Thus, the inhibition of factor Xa by C921-78 follows a mechanism similar to that described classically for slow tight binding inhibitors. However, the two steps of the reaction cannot be kinetically separated by the rapid equilibrium assumption, and therefore, the formation of EI is partially rate-limiting, too. The driving energy for the unusually fast isomerization step may result from the highly favorable interactions of the inhibitor in the primary binding site.Keywords
This publication has 14 references indexed in Scilit:
- Rational Design and Synthesis of Novel, Potent Bis-phenylamidine Carboxylate Factor Xa InhibitorsJournal of Medicinal Chemistry, 1998
- Evidence of a Conformational Change in the Human Cytomegalovirus Protease upon Binding of Peptidyl-Activated Carbonyl InhibitorsBiochemistry, 1997
- Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding siteBiophysical Journal, 1996
- X-ray Structure of Active Site-inhibited Clotting Factor XaPublished by Elsevier ,1996
- TISSUE FACTOR PATHWAY INHIBITOR AND THE REVISED THEORY OF COAGULATIONAnnual Review of Medicine, 1995
- Deconvolutions based on singular value decomposition and the pseudoinverse: a guide for beginnersJournal of Biochemical and Biophysical Methods, 1994
- Evidence for common structural changes in thrombin induced by active-site or exosite bindingBiochemical Journal, 1993
- Design, synthesis, and kinetic evaluation of a unique class of elastase inhibitors, the peptidyl .alpha.-ketobenzoxazoles, and the x-ray crystal structure of the covalent complex between porcine pancreatic elastase and Ac-Ala-Pro-Val-2-benzoxazoleJournal of the American Chemical Society, 1992
- The action of Factor Xa on peptide p-nitroanilide substrates: substrate selectivity and examination of hydrolysis with different reaction conditionsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Theory and experimental method for determining individual kinetic constants of fast-acting, irreversible proteinase inhibitorsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1984